| This article has been cited by |
| 1 | OAE-based data mining and modeling analysis of adverse events associated with three licensed HPV vaccines | |
| Wenrui Zi,Qiuyue Yang,Jun Su,Yongqun He,Jiangan Xie |
| Heliyon.2022;8(11)e11515 |
| [DOI] |
|
| 2 | Post-approval Safety Monitoring of Quadrivalent and Bivalent Human Papillomavirus Vaccines Based on Real-world Data from the Korea Adverse Events Reporting System (KAERS) | |
| MoonJung Kim,SangHee Kim,Ju-Young Shin |
| Clinical Drug Investigation.2020;40(8)727 |
| [DOI] |
|
| 3 | Investigation on Spontaneous Abortion and Human Papillomavirus Infection | |
| Mauro Tognon,Andrea Tagliapietra,Federica Magagnoli,Chiara Mazziotta,Lucia Oton-Gonzalez,Carmen Lanzillotti,Fortunato Vesce,Carlo Contini,John Charles Rotondo,Fernanda Martini |
| Vaccines.2020;8(3)473 |
| [DOI] |
|
| 4 | Trends in Adolescent Human Papillomavirus Vaccination and Parental Hesitancy in the United States | |
| Jodie L White,M Kate Grabowski,Anne F Rositch,Patti E Gravitt,Thomas C Quinn,Aaron A R Tobian,Eshan U Patel |
| The Journal of Infectious Diseases.2023;8(3)473 |
| [DOI] |
|
| 5 | Risk of Guillain–Barré syndrome after vaccination against human papillomavirus: a systematic review and meta-analysis, 1 January 2000 to 4 April 2020 | |
| T Sonia Boender,Barbara Bartmeyer,Louise Coole,Ole Wichmann,Thomas Harder |
| Eurosurveillance.2022;27(4)473 |
| [DOI] |
|
| 6 | VelcroVax: a “Bolt-On” Vaccine Platform for Glycoprotein Display | |
| Natalie J. Kingston,Keith Grehan,Joseph S. Snowden,Mark Hassall,Jehad Alzahrani,Guido C. Paesen,Lee Sherry,Connor Hayward,Amy Roe,Sam Stephen,Darren Tomlinson,Antra Zeltina,Katie J. Doores,Neil A. Ranson,Martin Stacey,Mark Page,Nicola J. Rose,Thomas A. Bowden,David J. Rowlands,Nicola J. Stonehouse,Marcela F. Pasetti |
| mSphere.2023;8(1)473 |
| [DOI] |
|
| 7 | Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system | |
| Congqin Chen,Fang Fu,Lingqing Ding,Jie Fang,Jie Xiao |
| Frontiers in Immunology.2022;13(1)473 |
| [DOI] |
|
| 8 | The Development of Human Papillomavirus (HPV) Vaccines and Current Barriers to Implementation | |
| Rebecca Butterfield,Salimah Dhanani |
| Immunological Investigations.2021;50(7)821 |
| [DOI] |
|
| 9 | Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine using the national adverse event following immunization surveillance system from Zhejiang province, 2018-2020 | |
| Yu Hu,Xuejiao Pan,Linzhi Shen,Fuxing Chen,Ying Wang,Hui Liang,Yaping Chen,Huakun Lv |
| Human Vaccines & Immunotherapeutics.2021;17(12)5447 |
| [DOI] |
|
